Kalkidan Bishu, MD
Interventional Cardiology · Duluth, MNNPI 1881887818
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,710 of the $2,438 with a category attached, or 70.2%. Abbott accounts for 85.1% of it on its own, with 5 other manufacturers making up the rest. 2024 is the largest year on record at $1,890, 5.8 times the $328 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.
Across 24 payments — averaging $101.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$143
- Edwards Lifesciences$117
- Medtronic$69
- Shockwave Medical, Inc$22
- Angiodynamics, Inc.$12
What the payments were for
- Travel & lodging$1,71070%
- Food & beverage$72830%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 15 | $2,074 |
| Boston Scientific | 3 | $143 |
| Edwards Lifesciences | 2 | $117 |
| Medtronic | 2 | $69 |
| Shockwave Medical, Inc | 1 | $22 |
| Angiodynamics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$807
- Mitra Clip system$112
How this compares
$2,438 in reported general payments places this provider in the 30th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 176 | $177,262 |
| CamzyosMavacamten | 14 | $97,441 |
| XareltoRivaroxaban | 79 | $73,661 |
| Repatha SureclickEvolocumab | 64 | $54,630 |
| JardianceEmpagliflozin | 43 | $38,293 |
| EntrestoSacubitril/Valsartan | 21 | $22,812 |
| Praluent PenAlirocumab | 15 | $15,568 |
| BrilintaTicagrelor | 15 | $12,573 |
| Repatha SyringeEvolocumab | 12 | $6,464 |
| Metoprolol Succinate | 292 | $4,449 |
| Atorvastatin Calcium | 333 | $3,799 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 171 | $2,679 |
| Torsemide | 86 | $2,574 |
| Ezetimibe | 111 | $2,245 |
| Amiodarone Hcl | 72 | $1,910 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Duluth
- Leif ChristiansonDuluth$5K
- Wilson GineteDuluth$4K
- Jason SchultzDuluth$3K
- Faraz Nasim KazmiDuluth$2K
- Thom DahleSaint Cloud$1.1M
- Stephen KiddSaint Cloud$607K
- Brian StegmanSt Cloud$587K
- Emmanouil BrilakisMinneapolis$548K
- Wesley PedersenMinneapolis$493K
- Michael ManolesMinneapolis$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.